Not found

Jilu Zhang, PhD

Instructor of Oncology, Academic Institute
Instructor, Research Institute
Houston Methodist


Publications

The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells
Zhang, J, Chen, H-M, Ma, G, Zhou, Z, Raulet, D, Rivera, AL, Chen, S-H & Pan, P-Y 2019, , Leukemia, vol. 33, no. 8, pp. 2078-2089. https://doi.org/10.1038/s41375-019-0394-z

ST2/MyD88 deficiency protects mice against acute graft-versus-host disease and spares regulatory T cells
Griesenauer, B, Jiang, H, Yang, J, Zhang, J, Ramadan, AM, Egbosiuba, J, Campa, K & Paczesny, S 2019, Journal of Immunology, vol. 202, no. 10, pp. 3053-3064. https://doi.org/10.4049/jimmunol.1800447

Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease
Yang, J, Ramadan, A, Reichenbach, DK, Loschi, M, Zhang, J, Griesenauer, B, Liu, H, Hippen, KL, Blazar, BR & Paczesny, S 2019, JCI insight, vol. 4, no. 5. https://doi.org/10.1172/jci.insight.122014

Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity
Chen, H-M, van der Touw, W, Wang, YS, Kang, K, Mai, S, Zhang, J, Alsina-Beauchamp, D, Duty, JA, Mungamuri, SK, Zhang, B, Moran, T, Flavell, R, Aaronson, S, Hu, H-M, Arase, H, Ramanathan, S, Flores, R, Pan, P-Y & Chen, S-H 2018, , The Journal of clinical investigation, vol. 128, no. 12, pp. 5647-5662. https://doi.org/10.1172/JCI97570

From proteomics to discovery of first-in-class ST2 inhibitors active in vivo
Ramadan, AM, Daguindau, E, Rech, JC, Chinnaswamy, K, Zhang, J, Hura, GL, Griesenauer, B, Bolten, Z, Robida, A, Larsen, M, Stuckey, JA, Yang, CY & Paczesny, S 2018, , JCI insight, vol. 3, no. 14. https://doi.org/10.1172/jci.insight.99208

Leukocyte immunoglobulin-like receptors in human diseases: An overview of their distribution, function, and potential application for immunotherapies
Zhang, J, Mai, S, Chen, H-M, Kang, K, Li, XC, Chen, SH & Pan, PY 2017, , Journal of Leukocyte Biology, vol. 102, no. 2, pp. 351-360. https://doi.org/10.1189/jlb.5MR1216-534R

Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease
Li, W, Liu, L, Gomez, A, Zhang, J, Ramadan, A, Zhang, Q, Choi, SW, Zhang, P, Greenson, JK, Liu, C, Jiang, D, Virts, E, Kelich, SL, Chu, HW, Flynn, R, Blazar, BR, Hanenberg, H, Hanash, S & Paczesny, S 2016, , JCI insight, vol. 1, no. 6. https://doi.org/10.1172/jci.insight.86660

ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease
Zhang, J, Ramadan, AM, Griesenauer, B, Li, W, Turner, MJ, Liu, C, Kapur, R, Hanenberg, H, Blazar, BR, Tawara, I & Paczesny, S 2015, , Science translational medicine, vol. 7, no. 308, 308ra160. https://doi.org/10.1126/scitranslmed.aab0166

Therapeutic effects and possible mechanisms of sirolimus on nephritic mice with chronic rejection
Zheng, MK, Hou, CM, Wang, RX, Wei, YL, Zhang, J, Li, XY, Chen, GJ, Han, GC, Shen, BF, Li, Y, Ma, YF & Xiao, H 2014, Journal of International Pharmaceutical Research, vol. 41, no. 3, pp. 335-341. https://doi.org/10.13220/j.cnki.jipr.2014.03.014

[Influence of excessive complement activation on pathological process of acute graft versus host disease in mice].
Zhang, J, Hou, CM, Wei, YL, Li, XY, Sun, DJ, Feng, JN, Li, Y, Shen, BF & Xiao, H 2010, , Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology, vol. 18, no. 6, pp. 1585-1589.

CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3 + regulatory T cells in the target tissue: Kidney
Zhang, J, Sun, DJ, Hou, CM, Wei, YL, Li, XY, Yu, ZY, Feng, JN, Shen, BF, Li, Y & Xiao, H 2010, , Transplant Immunology, vol. 24, no. 1, pp. 17-25. https://doi.org/10.1016/j.trim.2010.09.002

Reply to "reply to 'The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rates in hematologic malignancy patients: Outcome of a pilot clinical study' by Ning H et al." by Behre et al
Ning, H, Yang, F, Jiang, M, Hu, L, Feng, K, Zhang, J, Yu, Z, Li, B, Xu, C, Li, Y, Wang, J, Hu, J, Lou, X & Chen, H 2009, , Leukemia, vol. 23, no. 1, pp. 179-180. https://doi.org/10.1038/leu.2008.151

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: Outcome of a pilot clinical study
Ning, H, Yang, F, Jiang, M, Hu, L, Feng, K, Zhang, J, Yu, Z, Li, B, Xu, C, Li, Y, Wang, J, Hu, J, Lou, X & Chen, H 2008, , Leukemia, vol. 22, no. 3, pp. 593-599. https://doi.org/10.1038/sj.leu.2405090

VIEW FULL PUBLICATIONS